Physician profile
David Hogarty
NPI 1760447528
$2,897.37
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $913 · 2020: $1,110 · 2021: $859 · 2023: $15.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $840.14 | 2019-2021 | |
| Janssen Biotech, INC. | $370.64 | 2019-2021 | |
| Abbvie INC. | $323.43 | 2019-2023 | |
| Ucb, INC. | $282.19 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $164.44 | 2020-2021 | |
| Lilly USA, LLC | $162.51 | 2020-2021 | |
| Horizon Therapeutics Plc | $113.87 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $103.27 | 2019-2020 | |
| Pfizer INC. | $90.15 | 2019-2020 | |
| Akcea Therapeutics, INC. | $87.84 | 2019 | |
| Fidia Pharma USA INC. | $79.47 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.01 | 2020-2021 | |
| Hikma Pharmaceuticals USA | $44.99 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $28.87 | 2019-2020 | |
| Genzyme Corporation | $24.46 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $20.25 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $19.32 | 2021 | |
| Mallinckrodt Hospital Products INC. | $18.48 | 2020 | |
| Radius Health, INC. | $15.68 | 2019 | |
| Medexus Pharma, INC. | $15.34 | 2019 | |
| Aurinia Pharma U.S., INC. | $14.98 | 2021 | |
| Alexion Pharmaceuticals, INC. | $13.92 | 2020 | |
| Depuy Synthes Sales INC. | $11.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hogarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.